Insights
Unbranded biosimilar 95% below the cost of Humira available through the Bayvrio Marketplace
Bayvrio has added an unbranded biosimilar to Humira® (adalimumab) to the Bayvrio Marketplace, available to any hospital or licensed specialty pharmacy in the U.S. Priced ...
Flexibility, Choice, and the Future of Pharmacy
Pharmacy is at a turning point. For decades, healthcare payers have been locked into rigid, bundled contracts that lack transparency and limit innovation. Across other ...
Bayvrio offers unbranded biosimilar to expand payer choice, access, and affordability
Clinically interchangeable drug will be available to any licensed specialty pharmacy in the U.S. through Bayvrio Marketplace supplier, Birdi, Inc. Bayvrio today announced that an ...
First-of-its-kind marketplace gives payers full control over pharmacy benefits
Payers can choose from best-in-class solutions and suppliers to build, manage, and deliver pharmacy benefit and healthcare strategies tailored to their needs and goals TAMPA, ...
Investment accelerates rollout of advanced technology and curated solutions
Strategic investment will radically change how payers manage benefits, costs, and care SAN DIEGO, CA AND TAMPA, FL – MedImpact Holdings’ strategic investment in health tech ...
Pharmacy benefits should work for you – not the other way around. At Bayvrio, we are helping to ensure your pharmacy benefits work better and smarter for everyone, so you can focus on what matters most – your members.
Zach Johnson | Founder & CEO
